Classification is a two-step process, learning step and prediction step, in machine learning. In the learning step, the model is developed based on given training data. In the prediction step, the model is used to predict the response for given data. Decision Tree is one of the easiest and popular classification algorithms to understand and interpret. Decision Tree algorithm belongs to the family of supervised learning algorithms.

Addressing the need for explainable Machine Learning has emerged as one of the most important research directions in modern Artificial Intelligence (AI). While the current dominant paradigm in the field is based on black-box models, typically in the form of (deep) neural networks, these models lack direct interpretability for human users, i.e., their outcomes (and, even more so, their inner working) are opaque and hard to understand. This is hindering the adoption of AI in safety-critical applications, where high interests are at stake. In these applications, explainable by design models, such as decision trees, may be more suitable, as they provide interpretability. Recent works have proposed the hybridization of decision trees and Reinforcement Learning, to combine the advantages of the two approaches. So far, however, these works have focused on the optimization of those hybrid models. Here, we apply MAP-Elites for diversifying hybrid models over a feature space that captures both the model complexity and its behavioral variability. We apply our method on two well-known control problems from the OpenAI Gym library, on which we discuss the "illumination" patterns projected by MAP-Elites, comparing its results against existing similar approaches.

Artificial intelligence and machine learning techniques are breaking into biomedical research and health care, which importantly includes cancer research and oncology, where the potential applications are vast. These include detection and diagnosis of cancer, subtype classification, optimization of cancer treatment and identification of new therapeutic targets in drug discovery. While big data used to train machine learning models may already exist, leveraging this opportunity to realize the full promise of artificial intelligence in both the cancer research space and the clinical space will first require significant obstacles to be surmounted. In this Viewpoint article, we asked four experts for their opinions on how we can begin to implement artificial intelligence while ensuring standards are maintained so as transform cancer diagnosis and the prognosis and treatment of patients with cancer and to drive biological discovery. In this Viewpoint article, we asked four experts to share their thoughts on the implementation of artificial intelligence and machine learning techniques into cancer research and care, and how to separate the hope from the hype to overcome the challenges ahead.

A common approach to aggregate classification estimates in an ensemble of decision trees is to either use voting or to average the probabilities for each class. The latter takes uncertainty into account, but not the reliability of the uncertainty estimates (so to say, the "uncertainty about the uncertainty"). More generally, much remains unknown about how to best combine probabilistic estimates from multiple sources. In this paper, we investigate a number of alternative prediction methods. Our methods are inspired by the theories of probability, belief functions and reliable classification, as well as a principle that we call evidence accumulation. Our experiments on a variety of data sets are based on random decision trees which guarantees a high diversity in the predictions to be combined. Somewhat unexpectedly, we found that taking the average over the probabilities is actually hard to beat. However, evidence accumulation showed consistently better results on all but very small leafs.

This paper proposes a framework based on a causal model of safety upon which effective safety assurance cases for ML-based applications can be developed. In doing so, we build upon established principles of safety engineering as well as previous work on structuring assurance arguments for ML. The paper defines four categories of safety case evidence and a structured analysis approach within which these evidences can be effectively combined. Where appropriate, abstract formalisations of these contributions are used to illustrate the causalities they evaluate, their contributions to the safety argument and desirable properties of the evidences. Based on the proposed framework, progress in this area is re-evaluated and a set of future research directions proposed in order for tangible progress in this field to be made.

Cancer is one of the leading causes of death worldwide. Fast and safe early-stage, pre- and intra-operative diagnostics can significantly contribute to successful cancer identification and treatment. Artificial intelligence has played an increasing role in the enhancement of cancer diagnostics techniques in the last 15 years. This review covers the advances of artificial intelligence applications in well-established techniques such as MRI and CT. Also, it shows its high potential in combination with optical spectroscopy-based approaches that are under development for mobile, ultra-fast, and low-invasive diagnostics. I will show how spectroscopy-based approaches can reduce the time of tissue preparation for pathological analysis by making thin-slicing or haematoxylin-and-eosin staining obsolete. I will present examples of spectroscopic tools for fast and low-invasive ex- and in-vivo tissue classification for the determination of a tumour and its boundaries. Also, I will discuss that, contrary to MRI and CT, spectroscopic measurements do not require the administration of chemical agents to enhance the quality of cancer imaging which contributes to the development of more secure diagnostic methods. Overall, we will see that the combination of spectroscopy and artificial intelligence constitutes a highly promising and fast-developing field of medical technology that will soon augment available cancer diagnostic methods.

Bearing fault diagnosis is of great importance to decrease the damage risk of rotating machines and further improve economic profits. Recently, machine learning, represented by deep learning, has made great progress in bearing fault diagnosis. However, applying deep learning to such a task still faces a major problem. A deep network is notoriously a black box. It is difficult to know how a model classifies faulty signals from the normal and the physics principle behind the classification. To solve the interpretability issue, first, we prototype a convolutional network with recently-invented quadratic neurons. This quadratic neuron empowered network can qualify the noisy bearing data due to the strong feature representation ability of quadratic neurons. Moreover, we independently derive the attention mechanism from a quadratic neuron, referred to as qttention, by factorizing the learned quadratic function in analogue to the attention, making the model with quadratic neurons inherently interpretable. Experiments on the public and our datasets demonstrate that the proposed network can facilitate effective and interpretable bearing fault diagnosis.

Causal relationships are commonly examined in manufacturing processes to support faults investigations, perform interventions, and make strategic decisions. Industry 4.0 has made available an increasing amount of data that enable data-driven Causal Discovery (CD). Considering the growing number of recently proposed CD methods, it is necessary to introduce strict benchmarking procedures on publicly available datasets since they represent the foundation for a fair comparison and validation of different methods. This work introduces two novel public datasets for CD in continuous manufacturing processes. The first dataset employs the well-known Tennessee Eastman simulator for fault detection and process control. The second dataset is extracted from an ultra-processed food manufacturing plant, and it includes a description of the plant, as well as multiple ground truths. These datasets are used to propose a benchmarking procedure based on different metrics and evaluated on a wide selection of CD algorithms. This work allows testing CD methods in realistic conditions enabling the selection of the most suitable method for specific target applications. The datasets are available at the following link: https://github.com/giovanniMen

Working with causal models at different levels of abstraction is an important feature of science. Existing work has already considered the problem of expressing formally the relation of abstraction between causal models. In this paper, we focus on the problem of learning abstractions. We start by defining the learning problem formally in terms of the optimization of a standard measure of consistency. We then point out the limitation of this approach, and we suggest extending the objective function with a term accounting for information loss. We suggest a concrete measure of information loss, and we illustrate its contribution to learning new abstractions.

Scottish and European health researchers have announced that they are part of a €6m international project to use AI to improve the diagnosis of bowel cancer, the UK's second-most deadly type of cancer. Bowel cancer is the second most-common cause of cancer death in Scotland, with around 1,600 people dying of the disease each year. The current detection method involves inserting an endoscope, a thin flexible tube with a camera on the end, into a patient's colon which then travels around the large bowel allowing doctors to check for cancer. The new procedure being developed by the research team - known as a Clinical Capsule Endoscopy (CCE) – utilises an artificial intelligence-assisted'smart pill' containing cameras (pictured below) which, once swallowed by a patient, records images of the intestines as it passes through. At present, images captured by the capsules are reviewed by trained doctors, but AI offers the potential to safely and ethically speed up the process, make it more cost-effective and increase its use.